• Recent news

  • Biotec Pharmacon ASA – Notice of Extraordinary General Meeting

    Tromsø, 13 December 2019: Biotec Pharmacon (OSE: Biotec) will hold an extraordinary general meeting on Monday 6. January 2020 at 12.30 CET at Hotell Continental, Stortingsgata 24/26, Oslo The primary purpose of the meeting is to elect a new member to the Board of Directors. Please find the notice including agenda for the meeting and appendices attached to…

    Continue reading

Latest presentation

Fourth quarter 2019 results

Loading video...

Biotec Pharmacon Q4 2019 Report Tromsø, Norway, 30 January 2020 – Biotec Pharmacon (OSE: Biotec) announces its fourth quarter and 2019 results. Highlights from Q4 2019 Positive EBITDA with NOK 4.6 million (Q4 2018: NOK 1.8 million)* mainly due to ArcticZymes sales. Accruals for onetime expenses relating to restructuring costs amounting to…

View more